Asthma Clinical Trials in Chicago

Showing 81-100 of 223 trials

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

NCT01222247

This is a randomized placebo controlled trial to evaluate whether antenatal corticosteroids can decrease the rate of neonatal respiratory support, thus decreasing the rate of NICU admissions and improving short-term outcomes in the late preterm infant. The use of antenatal corticosteroids has been shown to be beneficial in women at risk for preterm delivery prior to 34 weeks but has not been evaluated in those likely to deliver in the late preterm period

PregnancyRespiratory Distress SyndromePregnancy Outcomes+1 more

The George Washington University Biostatistics Center2,831 participantsStarted Oct 2010

Birmingham, Alabama, United States • Stanford, California, United States • Denver, Colorado, United States +14 more locations

COMPLETEDPHASE22.2 miles

Trial of Roflumilast in Asthma Management (TRIM)

NCT03532490

There are currently no treatments to specifically target asthma in obese adults. This pilot study is being conducted to investigate how effective roflumilast is in treating asthma in participants that have a higher BMI. Roflumilast can induce weight loss, which may lead to improved asthma control. The primary objective of TRIM is to perform a pilot placebo-controlled trial of roflumilast for the treatment of poorly controlled obese asthmatics.

AsthmaObesity

Johns Hopkins University38 participantsStarted Aug 2018

Birmingham, Alabama, United States • Tucson, Arizona, United States • Chicago, Illinois, United States +4 more locations

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

Trial of Roflumilast in Asthma Management (TRIM)

Asthma Trials in Other Cities

The Impact of High-Flow Nasal Cannula on Swallow Function

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Early Mobilization in the ICU

Virtual Teach to Goal vs. Brief Intervention Inhaler Study-outpatient

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics

Improving Quality by Maintaining Accurate Problems in the EHR

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies

Other Conditions in Chicago